NanoViricides
NNVC
#10606
Rank
$32.54 M
Marketcap
$1.28
Share price
-1.92%
Change (1 day)
-10.21%
Change (1 year)

NanoViricides (NNVC) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : $1.06 Million USD

According to NanoViricides's latest financial reports the company's total liabilities are $1.06 Million USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

NanoViricides - Total liabilities on balance sheet (from 2006 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-06-30$1.3 M-3.85%
2024-06-30$1.35 M-33.21%
2023-06-30$2.03 M392.75%
2022-06-30$0.41 M17.57%
2021-06-30$0.35 M-83.72%
2020-06-30$2.15 M-24.29%
2019-06-30$2.84 M222.94%
2018-06-30$0.88 M-86.8%
2017-06-30$6.68 M-50.82%
2016-06-30$13.58 M9.55%
2015-06-30$12.4 M-39.48%
2014-06-30$20.49 M144%
2013-06-30$8.39 M371.89%
2012-06-30$1.77 M203.08%
2011-06-30$0.58 M-76.26%
2010-06-30$2.47 M379.65%
2009-06-30$0.51 M-49.66%
2008-06-30$1.02 M20.55%
2007-06-30$0.84 M-43%
2006-06-30$1.49 M2159.13%
2005-06-30$0.06 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Gilead Sciences
GILD
$37.61 B 3,530,747.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$87.81 B 8,242,548.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$65.31 B 6,130,403.75%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$59.04 B 5,542,010.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
$1.14 B 107,490.51%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
$1.01 B 94,900.05%๐Ÿ‡บ๐Ÿ‡ธ USA